Sasaki E - Search Results

1

Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.

Naito Y, Yoshikawa T, Iinuma S, Yagi N, Matsuyama K, Boku Y, Fujii T, Yoshida N, Kondo M, Sasaki E. Naito Y, et al. Among authors: sasaki e. Dig Dis Sci. 1998 Sep;43(9 Suppl):83S-89S. Dig Dis Sci. 1998. PMID: 9753232 Clinical Trial.

2

Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.

Sano Y, Hashimoto E, Nakatani N, Abe M, Satoh Y, Sakata K, Fujii T, Fujimoto-Ouchi K, Sugimoto M, Nagahashi S, Aoki M, Motegi H, Sasaki E, Yatabe Y. Sano Y, et al. Among authors: sasaki e. Mol Cancer Ther. 2015 Feb;14(2):533-41. doi: 10.1158/1535-7163.MCT-14-0456. Epub 2014 Dec 18. Mol Cancer Ther. 2015. PMID: 25522765

3

Immunohistochemical detection of EGFR mutation using mutation-specific antibodies in lung cancer.

Kitamura A, Hosoda W, Sasaki E, Mitsudomi T, Yatabe Y. Kitamura A, et al. Among authors: sasaki e. Clin Cancer Res. 2010 Jul 1;16(13):3349-55. doi: 10.1158/1078-0432.CCR-10-0129. Epub 2010 Jun 22. Clin Cancer Res. 2010. PMID: 20570926

4

HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells.

Sakuma K, Sasaki E, Kimura K, Komori K, Shimizu Y, Yatabe Y, Aoki M. Sakuma K, et al. Among authors: sasaki e. Cancer Sci. 2018 Aug;109(8):2458-2468. doi: 10.1111/cas.13660. Epub 2018 Jul 16. Cancer Sci. 2018. PMID: 29869816 Free PMC article.

5

Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion.

Sasaki E, Nishikawa D, Hanai N, Hasegawa Y, Yatabe Y. Sasaki E, et al. Histopathology. 2018 Dec;73(6):953-962. doi: 10.1111/his.13732. Epub 2018 Oct 23. Histopathology. 2018. PMID: 30117182

6

MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.

Sakuma K, Sasaki E, Hosoda W, Komori K, Shimizu Y, Yatabe Y, Aoki M. Sakuma K, et al. Among authors: sasaki e. Cancer Sci. 2021 Sep;112(9):3846-3855. doi: 10.1111/cas.15069. Epub 2021 Jul 29. Cancer Sci. 2021. PMID: 34286904 Free PMC article.

7

HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.

Sakuma K, Sasaki E, Kimura K, Komori K, Shimizu Y, Yatabe Y, Aoki M. Sakuma K, et al. Among authors: sasaki e. Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30. Gut. 2018. PMID: 28360095

8

Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.

Seto K, Haneda M, Masago K, Fujita S, Kato S, Sasaki E, Hosoda W, Murakami Y, Kuroda H, Horio Y, Hida T, Okubo K, Yatabe Y. Seto K, et al. Among authors: sasaki e. Pathol Int. 2020 May;70(5):253-261. doi: 10.1111/pin.12903. Epub 2020 Jan 23. Pathol Int. 2020. PMID: 31970865

9

HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.

Sugano M, Nagasaka T, Sasaki E, Murakami Y, Hosoda W, Hida T, Mitsudomi T, Yatabe Y. Sugano M, et al. Among authors: sasaki e. Am J Surg Pathol. 2013 Feb;37(2):211-8. doi: 10.1097/PAS.0b013e31826be303. Am J Surg Pathol. 2013. PMID: 23108025

10

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck.

Sasaki E, Masago K, Fujita S, Hanai N, Yatabe Y. Sasaki E, et al. J Pathol Clin Res. 2020 Apr;6(2):154-159. doi: 10.1002/cjp2.157. Epub 2020 Jan 20. J Pathol Clin Res. 2020. PMID: 31960612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

854 results

Search Page

Filters